Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Serina Therapeutics, Inc. (SER) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Serina Therapeutics, Inc. (SER), most recent 12 months reported: revenue $130K, net loss $21.18M, free cash flow -$21.2M. Latest balance sheet on file: liquid cash $23.02M, total debt $3.09M, net cash $19.94M. From SEC filings. Others in Pharmaceutical Preparations: REGEN BIOPHARMA, INC. · Clene Inc. · LEXARIA BIOSCIENCE CORP. · Lisata Therapeutics, Inc. · VYOME HOLDINGS, INC. · BULLFROG AI HOLDINGS, INC. · IBIO, INC. · ASPIRE BIOPHARMA HOLDINGS, INC.

Stock screener

Watchlist